The Duration and Safety of Osteoporosis Treatment: Anabolic and Antiresorptive Therapy

Author:   Stuart Silverman ,  Bo Abrahamsen
Publisher:   Springer International Publishing AG
Edition:   1st ed. 2016
ISBN:  

9783319236384


Pages:   338
Publication Date:   08 January 2016
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $290.37 Quantity:  
Add to Cart

Share |

The Duration and Safety of Osteoporosis Treatment: Anabolic and Antiresorptive Therapy


Add your own review!

Overview

Full Product Details

Author:   Stuart Silverman ,  Bo Abrahamsen
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   1st ed. 2016
Dimensions:   Width: 17.80cm , Height: 2.10cm , Length: 25.40cm
Weight:   7.489kg
ISBN:  

9783319236384


ISBN 10:   3319236385
Pages:   338
Publication Date:   08 January 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Foreword.- Preface.- Osteoporosis: Pathophysiology & Epidemiology.- Antiresorptives.- Anabolics.- Tools for Assessing Fracture Risk and for Treatment Monitoring.- Treatment Failure.- Epidemiology of Atypical Subtrochanteric and Femoral Shaft Fractures.- Bisphosphonate-Related Atypical Femoral Fractures and Their Radiographic Features.- Factors Contributing to Atypical Femoral Fractures.- Clinical Presentation of Atypical Femur Fractures.- Effects of Antiresorptive Therapy on Bone Microarchitecture.- Management of Atypical Femoral Fractures.- Osteonecrosis of the Jaw: Clinico-Pathologic and Radiologic Features.- Epidemiology of Osteonecrosis of the Jaws from Antiresorptive Treatment.- Management of Osteonecrosis of the Jaw in Patients Receiving Antiresorptive Treatment.- Long-Term Efficacy and Safety of Treatments for Osteoporosis.- Management of Drug Holidays.- Patients Who Do Not Take Their Osteoporosis Medications:  Can We Help Them Become Compliant?.- Fractures andHealing on Antiresorptive Therapy.- Antiresorptive Therapy and Mortality and Cancer Incidence.- Other Safety Concerns.- The Impact of Regulatory and Scientific Organizations Recommendations on Clinical Decision Making.- Integrated Clinical View on Long-Term Management of Patients with Osteoporosis.- Conclusions.

Reviews

Author Information

Stuart L. Silverman, MD, FACP, FACR Cedars-Sinai Medical Center Division of Rheumatology Department of Medicine Los Angeles, CA, USA University of California Los Angeles David Geffen School of Medicine Los Angeles, CA, USA Bo Abrahamsen, MD, PhD University of Southern Denmark Odense Patient Data Explorative Network Institute of Clinical Research Odense, Denmark Holbæk Hospital Department of Medicine Holbæk, Denmark

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List